2Pichat P;Angel I;Arbilla S.Anti-inflammatory properties of mizolastine after oral administration on arachidonic acid-induced cutaneous reaction in the rat,1998(01).
3Benavides J;Schoemaker H;Dana C.In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent,1995.
4Dubertr;Murrieta Aguttes M;Tonet J.Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria:results of the MILOR Study[J],1999.
5Sabbah A;Daele J;Wade AG.Comparison of the efficacy,safety,and onset of action of mizolastine,cetirizine,and placebo in the management of seasonal allergic rhinoconjunctivitis.MIZOCET Study Group[J],1999.
6Leynadier F;Duarte-Risselin C;Murrieta M.Comparative therapeutic effect and safety of mizolastine and loratadine in chronic idiopathic urticaria URTILOR study group,2000.
4Nijmeijer S, Leurs R, Vischer H F. Constitutive activity of the hista- mine H( 1 ) receptor[ J ]. Methods Enzymol,2010,484: 127 - 147.
5Mizuguchi H, Ono S, Hattori M, et al. Inverse agonistic activity of anti- histamines and suppression of histamine Hi receptor gene expression [J]. J Pharmacol Sci,2012,118(1) : 117 -21.
6Tanizaki H, Ikoma A, Fukuoka M, et al. Effects of bepotastine and fexofenadine on histamine -induced flare, wheal and itch[ J]. Int Arch Allergy Immunol,2012,158 (2) : 191 - 195.
7Scaglione F. Safety profile of bilastine: 2rid generation H1 - antihista- mines[J]. Eur Rev Med Pharmacol Sci,2012,16(14) : 1999 -2005.
